false
ar,be,bn,zh-CN,zh-TW,en,fr,de,hi,it,ja,ko,pt,ru,es,sw,vi
Catalog
Uterine mesenchymal neoplasms: new and evolving en ...
Recording
Recording
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In a webinar titled "Uterine Mesenchymal Neoplasms" by Dr. Brooke Howitt, a variety of new and evolving entities in gynecologic pathology were discussed. Dr. Howitt covered topics such as B-core high-grade endometrial stromal sarcomas, Cancel 1 rearranged sarcomas, and SMARC-deficient uterine sarcomas. These tumors often present challenges in diagnosis due to overlapping morphological features and variable immunophenotypes. Molecular testing was highlighted as an important tool to differentiate between these entities. Additionally, N-TRAK sarcomas, characterized by N-TRAK1 or N-TRAK3 gene fusions, were discussed, along with the potential for targeted therapy in these cases. Overall, the webinar emphasized the evolving landscape of gynecologic sarcomas and the importance of accurate diagnosis for appropriate management and treatment.
Keywords
Uterine Mesenchymal Neoplasms
Dr. Brooke Howitt
Gynecologic Pathology
B-core high-grade endometrial stromal sarcomas
Cancel 1 rearranged sarcomas
SMARC-deficient uterine sarcomas
Molecular Testing
N-TRAK sarcomas
Targeted Therapy
Contact
education@igcs.org
for assistance.
×